The Europe Ophthalmology Drugs and Devices Market is expected to expand over the forecast period of 2018-2026, by exhibiting a CAGR of 5.80%.The increase in the approvals from FDA which boosted the acceptance of drugs and devices and increased surgeries in ophthalmology market because of growing influence of refractive glitches are driving the growth in this market.

EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

Europe Ophthalmic Drugs & Devices Market Is Segmented by Ophthalmic Devices(Diagnostic & Monitoring Equipment, Surgery Device) by Vision Care(Contact Lens, Spectacles, Eye Exams) by Ophthalmic Drugs( by Prescription Type, by Drug Delivery Types, by Type of Disease, by Therapeutics) by End User(Hospitals, Eye Clinics, Diagnostic Centers, Patients) & Geography

Request free sample

Report Summary

The countries analyzed in the Europe region are UK, France, Germany, Spain, Italy and rest of Europe. The increased elderly population, increasing the total number of eye disorders, rising cost of healthcare and growing acceptance of less intrusive surgeries have all influenced the market growth. The risk concerned with ocular diseases and lack of knowledge amid people concerning ophthalmology are the reasons challenging the market.

There are many companies in the ophthalmology drugs and device market, of which major companies are Santen and Novartis AG. Other key companies include Sun Pharmaceuticals Industries Ltd, GlaxoSmithKline, Pfizer, Johnson & Johnson Inc, Allergan Inc, Essilor International S.A, Roche Holding Ag, Ziemer Group Holding Ag and Carl Zeiss Ag.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
RESEARCH METHODOLOGY
- SOURCES OF DATA
  - SECONDARY DATA
  - PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
  - VISION CARE DEVICES ARE DOMINATING THE MARKET
  - GLAUCOMA DRUGS ARE MAJORLY USED
  - RISING PREVALENCE OF EYE RELATED DISEASES

MARKET DETERMINANTS
- MARKET DRIVERS
  - INCREASING PREVALENCE OF DIABETES INCREASES PROBABILITY OF OPHTHALMIC DISORDERS
  - TECHNOLOGICAL ADVANCEMENT
  - INCREASE IN HEALTHCARE EXPENDITURE
- MARKET RESTRAINTS
  - RENOWNED DRUGS GOING OFF-PATENT
  - DELAY IN DRUG APPROVALS
  - AWARENESS RELATED TO OPHTHALMOLOGY DRUGS ARE LOW
- MARKET OPPORTUNITIES
  - INCREASE IN DISORDER SYMPTOM AND IMPROVED DIAGNOSIS LEADING TO HIGHER TREATMENT RATES
  - INCREASING DEMAND FOR INTRAOCULAR LENSES AND PHACOEMULSIFICATION DEVICES
- MARKET CHALLENGES
  - VARIOUS RISK AND COMPLICATIONS ASSOCIATED WITH THE TREATMENT OF OCULAR DISEASES

MARKET SEGMENTATION
- MARKET BY DRUGS AND DEVICES 2018-2026
  - DEVICES
    - DIAGNOSTIC & MONITORING EQUIPMENT
      - OPTICAL COHERENCE TOMOGRAPHY
      - OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
      - FUNDUS CAMERA MARKET
      - OPHTHALMOSCOPES
      - RETINOSCOPE
      - PACHYMETER
      - WAVEFRONT ABERROMETERS
      - PERIMETERS/VISUAL FIELD ANALYZER
      - AUTOREFRACTORS/PHOROPTER
      - SPECULAR MICROSCOPE
      - CORNEAL TOPOGRAPHERS
      - OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
    - SURGERY DEVICE
      - CATARACT SURGERY DEVICES
      - GLAUCOMA SURGERY DEVICES
      - REFRACTIVE SURGERY DEVICES
      - VITREORETINAL SURGERY DEVICES
    - VISION CARE
  - DRUGS
    - GLAUCOMA DRUG
    - RETINAL DISORDER DRUG
    - DRY EYE DRUG
    - ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG

KEY ANALYTICS
- PORTER’S FIVE FORCES ANALYSIS
  - BARGAINING POWER OF BUYERS
  - BARGAINING POWER OF SUPPLIER
  - THREATS OF NEW ENTRANTS
  - THREATS OF SUBSTITUTES
  - COMPETITIVE RIVALRY
- VALUE CHAIN ANALYSIS
  - RESEARCH AND DEVELOPMENT
  - MANUFACTURING
  - DISTRIBUTORS
  - END USERS
- KEY BUYING CRITERIA
  - COST
  - EFFICACY
  - ACCESSIBILITY
  - INNOVATION
- SUPPLY CHAIN ANALYSIS
  - SUPPLIERS
  - MANUFACTURERS
  - DISTRIBUTORS AND RETAILERS
  - END USERS
- REGULATORY FRAMEWORK
GEOGRAPHICAL ANALYSIS
- EUROPE
  - THE UK
  - FRANCE
  - GERMANY
  - SPAIN
  - ITALY
  - REST OF EUROPE

COMPANY PROFILES
- COMPETITIVE ANALYSIS
  - MARKET SHARE ANALYSIS
  - TOP COMPANIES
    - ESSILOR INTERNATIONAL S.A. (FRANCE)
    - JOHNSON & JOHNSON INC. (U.S.)
    - ALLERGAN PLC (U.S.)
    - NOVARTIS INTERNATIONAL AG (SWITZERLAND)
    - VALENT PHARMACEUTICALS INTERNATIONAL INC. (U.S.)
  - ALLERGAN INC.
    - COMPANY OVERVIEW
    - PRODUCT & SERVICES
    - SWOT ANALYSIS
    - STRATEGIC INITIATIVES
  - BAYER
    - COMPANY OVERVIEW
    - PRODUCT & SERVICES
    - SWOT ANALYSIS
    - STRATEGIC INITIATIVES
  - CARL ZEISS AG
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SWOT ANALYSIS
    - STRATEGIC INITIATIVE
  - ESSILOR INTERNATIONAL S.A.
    - COMPANY OVERVIEW
    - PRODUCT & SERVICES
    - SWOT ANALYSIS
    - STRATEGIC INITIATIVE
  - GLAXOSMITHKLINE
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SWOT ANALYSIS
  - JOHNSON & JOHNSON INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - NOVARTIS INTERNATIONAL AG
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - PFIZER
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - ROCHE HOLDING AG
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - SANTEN PHARMACEUTICAL CO., LTD.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVE
  - SUN PHARMACEUTICALS INDUSTRIES, LTD
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVE
  - VALENT PHARMACEUTICALS INTERNATIONAL INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVE
  - ZIEMER GROUP HOLDING AG
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVE

LIST OF TABLES

TABLE 1 EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026

TABLE 2 COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY

TABLE 3 SELECTED LIST OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS

TABLE 4 EYE DRUGS GONE OFF-PATENT

TABLE 5 EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2018-2026 ($ MILLION)

TABLE 6 EUROPE DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)

TABLE 7 EUROPE DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT BY TYPES 2018-2026 ($ MILLION)

TABLE 8 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2018-2026 ($ MILLION)

TABLE 9 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2018-2026 ($ MILLION)

TABLE 10 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2018-2026 ($ MILLION)

TABLE 11 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2018-2026 ($ MILLION)

TABLE 12 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2018-2026 ($ MILLION)

TABLE 13 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2018-2026 ($ MILLION)

TABLE 14 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2018-2026 ($ MILLION)

TABLE 15 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2018-2026 ($ MILLION)

TABLE 16 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2018-2026 ($ MILLION)

TABLE 17 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2018-2026 ($ MILLION)

TABLE 18 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2018-2026 ($ MILLION)

TABLE 19 EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2018-2026 ($ MILLION)

TABLE 20 EUROPE DEVICES MARKET IN SURGERY DEVICE BY TYPES 2018-2026 ($ MILLION)

TABLE 21 EUROPE SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2018-2026 ($ MILLION)

TABLE 22 EUROPE SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2018-2026 ($ MILLION)

TABLE 23 EUROPE SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2018-2026 ($ MILLION)

TABLE 24 EUROPE SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2018-2026 ($ MILLION)

TABLE 25 EUROPE DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)

TABLE 26 EUROPE DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2018-2026 ($ MILLION)

TABLE 27 EUROPE DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)

TABLE 28 EUROPE DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)

TABLE 29 EUROPE DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)

TABLE 30 EUROPE DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)

TABLE 31 EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

LIST OF FIGURES

FIGURE 1 EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026

FIGURE 2 EUROPE DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)

FIGURE 3 EUROPE DEVICES MARKET DIAGNOSTIC & MONITORING EQUIPMENT IN 2018-2026 ($ MILLION)

FIGURE 4 EUROPE DEVICES MARKET IN SURGERY DEVICE 2018-2026 ($ MILLION)

FIGURE 5 EUROPE DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)

FIGURE 6 EUROPE DRUGS AND DEVICES MARKET IN DRUGS 2018-2026 ($ MILLION)

FIGURE 7 EUROPE DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)

FIGURE 8 EUROPE DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)

FIGURE 9 EUROPE DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)

FIGURE 10 EUROPE DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)

FIGURE 11 EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 12 THE UK OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 13 FRANCE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 14 GERMANY OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 15 SPAIN OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 16 ITALY OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 17 REST OF EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 18 OPHTHALMOLOGY DEVICES COMPANY MARKET SHARE 2017 (%)

FIGURE 19 OPHTHALMOLOGY DRUGS COMPANY MARKET SHARE 2017 (%)

Segmentation

GEOGRAPHICAL ANALYSIS
- EUROPE
  - THE UK
  - FRANCE
  - GERMANY
  - SPAIN
  - ITALY
  - REST OF EUROPE

MARKET SEGMENTATION
- MARKET BY DRUGS AND DEVICES 2018-2026
  - DEVICES
    - DIAGNOSTIC & MONITORING EQUIPMENT
      - OPTICAL COHERENCE TOMOGRAPHY
      - OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
      - FUNDUS CAMERA MARKET
      - OPHTHALMOSCOPES
      - RETINOSCOPE
      - PACHYMETER
      - WAVEFRONT ABERROMETERS
      - PERIMETERS/VISUAL FIELD ANALYZER
      - AUTOREFRACTORS/PHOROPTER
      - SPECULAR MICROSCOPE
      - CORNEAL TOPOGRAPHERS
      - OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
    - SURGERY DEVICE
      - CATARACT SURGERY DEVICES
      - GLAUCOMA SURGERY DEVICES
      - REFRACTIVE SURGERY DEVICES
      - VITREORETINAL SURGERY DEVICES
    - VISION CARE
  - DRUGS
    - GLAUCOMA DRUG
    - RETINAL DISORDER DRUG
    - DRY EYE DRUG
    - ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG